SAKAR HEALTHCARE
|
The Current P/S Ratio of SAKAR HEALTHCARE is 5.18.
| Share Price | ₹538.6 | Mar 10,2026 |
| Market Cap | ₹1,195.7 Cr | |
| Sales-TTM | ₹230.9 Cr | TTM-Consolidated Results |
| Price/Sales | 5.18x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,195.7 Cr] as on Mar 10,2026
(/) Sales [ ₹230.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.18x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '5.18 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !
The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.
Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE
PS Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.87x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 5.22x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2022 of 1.8x.
How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SAKAR HEALTHCARE | 230.9 | 5.18 | 1,195.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.66 | 434,999.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.40 | 169,139.0 |
| CIPLA LTD | 28,351.1 | 3.80 | 107,685.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.76 | 149,791.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.16 | 109,664.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.64 | 92,377.5 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.56 | 92,865.3 |
| LUPIN LTD | 26,150.5 | 4.09 | 106,982.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.25 | 74,682.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.38 | 57,168.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.25x |
| Max industry PS | 16.40x |
| Median industry PS | 5.18x |
| Average industry PS | 6.62x |
You may also like the below Video Courses